文献速递淋巴瘤

套细胞淋巴瘤将肿瘤相关巨噬细胞极化为M2样并促进肿瘤发生

Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis.
PubMed 文献 · Blood Adv · 2021-01-01

研究利用同系小鼠套细胞淋巴瘤(MCL)模型和人类MCL细胞系,发现MCL肿瘤中浸润F4/80+肿瘤相关巨噬细胞(TAM),且MCL细胞可将单核细胞来源巨噬细胞极化为CD163+、IL-10升高的M2样表型。M2样巨噬细胞分泌的IL-10通过激活STAT1信号促进MCL生长,而IL-10中和抗体或STAT1抑制可显著消除该效应,提示靶向巨噬细胞是MCL治疗策略的潜在方向。

要点

  • MCL肿瘤微环境中存在F4/80+ TAM浸润,并呈现M2/M1极化。
  • MCL细胞可诱导巨噬细胞向CD163+、IL-10升高的M2样表型极化。
  • M2样巨噬细胞通过IL-10-STAT1轴促进MCL生长,靶向该轴可抑制肿瘤。

核心结论

  • MCL与巨噬细胞形成肿瘤微环境网络,M2样巨噬细胞通过IL-10/STAT1促进MCL生长,支持巨噬细胞作为MCL治疗干预靶点。

研究设计与样本

  • 使用新建立的鼠源MCL细胞系FC-muMCL1在同系小鼠模型中鉴定TAM浸润与极化。
  • 使用人类MCL细胞系Mino、Granta和JVM2体外评估对单核细胞来源巨噬细胞极化的影响。
  • 将人MCL细胞系Mino与CD14+单核细胞共异种移植,比较肿瘤生长并评估脂质体氯膦酸盐清除巨噬细胞的效果。

主要发现

  • 同系小鼠淋巴瘤肿瘤中F4/80+ TAM极化为CD206+ M2和CD80+ M1表型。
  • MCL细胞使单核细胞来源巨噬细胞CD163+表达和IL-10水平升高,而M1标志CD80和IL-12水平未受影响。
  • Mino与CD14+单核细胞共异种移植较单独MCL细胞显著增加体内肿瘤生长(P < .001)。
  • 脂质体氯膦酸盐清除巨噬细胞可逆转CD14+单核细胞对MCL异种移植生长的促进作用(P < .001)。
  • IL-10中和抗体或STAT1抑制(氟达拉滨或STAT1短发夹RNA)显著消除MCL生长(P < .01)。

关键数值与推荐

  • CD14+单核细胞共移植增加MCL异种移植肿瘤生长,P < .001。
  • 脂质体氯膦酸盐清除巨噬细胞逆转CD14+单核细胞促生长效应,P < .001。
  • IL-10中和抗体或STAT1抑制消除MCL生长,P < .01。

临床怎么用

  • 提示在MCL治疗策略中可考虑靶向肿瘤相关巨噬细胞或其IL-10/STAT1信号轴。

局限性

  • 研究主要基于小鼠模型和体外细胞系,尚未在患者样本或临床试验中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tumor-associated macrophages (TAMs) are recognized as a hallmark of certain solid cancers and predictors of poor prognosis; however, the functional role of TAMs in lymphoid malignancies, including B-cell lymphoma, has not been well defined. We identified infiltration of F4/80+ TAMs in a syngeneic mouse model using the recently generated murine mantle cell lymphoma (MCL) cell line FC-muMCL1. Multicolor flow cytometric analysis of syngeneic lymphoma tumors showed distinct polarization of F4/80+ TAMs into CD206+ M2 and CD80+ M1 phenotypes. Using human MCL cell lines (Mino, Granta, and JVM2), we further showed that MCL cells polarized monocyte-derived macrophages toward an M2-like phenotype, as assessed by CD163+ expression and increased interleukin-10 (IL-10) level; however, levels of the M1 markers CD80 and IL-12 remained unaffected. To show that macrophages contribute to MCL tumorigenesis, we xenografted the human MCL cell line Mino along with CD14+ monocytes and compared tumor growth between these 2 groups. Results showed that xenografted Mino along with CD14+ monocytes significantly increased the tumor growth in vivo compared with MCL cells alone (P < .001), whereas treatment with liposomal clodronate (to deplete the macrophages) reversed the effect of CD14+ monocytes on growth of MCL xenografts (P < .001). Mechanistically, IL-10 secreted by MCL-polarized M2-like macrophages was found to be responsible for increasing MCL growth by activating STAT1 signaling, whereas IL-10 neutralizing antibody or STAT1 inhibition by fludarabine or STAT1 short hairpin RNA significantly abolished MCL growth (P < .01). Collectively, our data show the existence of a tumor microenvironmental network of macrophages and MCL tumor and suggest the importance of macrophages in interventional therapeutic strategies against MCL and other lymphoid malignancies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Le K, Sun J, Khawaja H, et al. Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis. Blood Adv. 2021. PMID: 34297045. doi:10.1182/bloodadvances.2020003871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。